Literature DB >> 7570336

Pathogenesis-based treatment of recurring subareolar breast abscesses.

M M Meguid1, A Oler, P J Numann, S Khan.   

Abstract

BACKGROUND: When a subareolar breast abscess (SBA) is incised and drained, an extraordinarily high frequency of recurrence is noted.
METHODS: To develop a pathogenesis-based treatment plan, 24 women with a total of 84 abscesses were monitored.
RESULTS: In nine women SBA was under the left areola, under the right, in 7 and in eight the SBA occurred either simultaneously or sequentially under both areolae. In 11 of 24 patients a chronic lactiferous duct fistula also existed. In four of 24 patients four SBAs were treated with antibiotics; alone; all recurred. In 16 of 24 patients initial treatment was incision and drainage plus antibiotics; all recurred. When the abscess plus the plugged lactiferous duct was excised, there were no recurrences; however, in four patients a new abscess in a different duct occurred, which was treated by en bloc resection of all subareolar ampullae, without further recurrence. Patients with a fistulous tract had the fistula, its feeding abscess, and its plugged lactiferous duct excised, without recurrence. In first time SBA the organism was usually staphylococcus; in recurrences mixed flora was isolated. Pathologic findings ranged from squamous metaplasia with keratinization of lactiferous ducts to chronic abscess.
CONCLUSIONS: The cause of SBA is plugging of lactiferous duct within the nipple by keratin. To prevent recurrence the abscessed ampulla with its plugged proximal duct needs excision.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7570336     DOI: 10.1016/s0039-6060(05)80049-2

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  11 in total

1.  Treatment of mammary duct fistula by fistulectomy and saucerization.

Authors:  N Beechey-Newman; A Kothari; D Kulkarni; H Hamed; I S Fentiman
Journal:  World J Surg       Date:  2006-01       Impact factor: 3.352

Review 2.  Breast Infection: A Review of Diagnosis and Management Practices.

Authors:  Eve Boakes; Amy Woods; Natalie Johnson; Naim Kadoglou
Journal:  Eur J Breast Health       Date:  2018-07-01

3.  Predictors of primary breast abscesses and recurrence.

Authors:  Ankit Bharat; Feng Gao; Rebecca L Aft; William E Gillanders; Timothy J Eberlein; Julie A Margenthaler
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

4.  Treatments for Periductal Mastitis: Systematic Review and Meta-Analysis.

Authors:  Huiying Xu; Ruidong Liu; Yanli Lv; Zhenhua Fan; Weimin Mu; Qingzhong Yang; Hui Fu; Yi Li
Journal:  Breast Care (Basel)       Date:  2021-02-18       Impact factor: 2.860

5.  Sonographically guided triamcinolone injection for the treatment of chronic post-operative mammillary fistula.

Authors:  J D Berná-Serna; J D Berná-Mestre; A Piñero
Journal:  Br J Radiol       Date:  2012-12       Impact factor: 3.039

6.  Male Zuska's disease.

Authors:  Shepard P Johnson; Christodoulos Kaoutzanis; George A Schaub
Journal:  BMJ Case Rep       Date:  2014-04-04

7.  [Mastitis with abscesses caused by esophageal fistula].

Authors:  Kai Witzel; Ursula Riester; Hartmut Arps; Hartmut Kronsbein; Tahar Benhidjeb
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

8.  Clinical characteristics, classification and surgical treatment of periductal mastitis.

Authors:  Yanna Zhang; Yidong Zhou; Feng Mao; Jinghong Guan; Qiang Sun
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

Review 9.  A Review of Inflammatory Processes of the Breast with a Focus on Diagnosis in Core Biopsy Samples.

Authors:  Timothy M D'Alfonso; Paula S Ginter; Sandra J Shin
Journal:  J Pathol Transl Med       Date:  2015-07-15

10.  Modified techniques versus Hadfield's procedure in patients with periductal mastitis.

Authors:  Kubilay Dalci; Serdar Gumus; Ahmet Gokhan Saritas; Mehmet Onur Gul; Ahmet Rencuzogullari; Atilgan Tolga Akcam; Abdullah Ulku; Melek Ergin; Gurhan Sakman
Journal:  BMC Surg       Date:  2022-02-05       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.